Advertisement
News
Subscribe to Pharmaceutical Processing News

The Lead

Amgen Wins Approval for Second Cholesterol Drug

August 28, 2015 | by Matthew Perrone, AP | Comments

Repatha is priced slightly below a similar drug, Praluent, which costs $14,600 per year. Analysts estimate eight to 10 million patients are covered under the FDA-approved labeling for the drugs.

TOPICS:

Doctor Faces Murder Trial After Three Overdose Deaths

September 1, 2015 12:09 pm | by Amanda Lee Myers, Associated Press | Comments

A California doctor is being charged after passing out prescriptions for powerful painkillers in appointments that lasted as little as three minutes and often without physical exams.

TOPICS:

Tablet Compression Training

August 31, 2015 12:48 pm | Comments

Natoli Engineering Company announces the opening of its Tablet Compression Resource center in Long Island, NY.

TOPICS:

"Candy Man" Guilty of Issuing Illegal Prescriptions

August 31, 2015 12:26 pm | by Amy Taxin, Associated Press | Comments

The father of a patient who died of an apparent overdose had repeatedly called Diaz's office, telling him his son was an addict and to stop giving him pills.

TOPICS:
Advertisement

Perrigo Acquires Scar Management Brand

August 31, 2015 12:14 pm | by PRNewswire | Comments

The brand is expected to generate approximately $10 million in full, calendar year 2015 net sales or approximately $3 million for the remainder of the year.

TOPICS:

Bristol-Myers Buys Fibrosis Drug

August 31, 2015 12:09 pm | by The Associated Press | Comments

Under the terms of the deal, Bristol-Myers Squibb will make an upfront payment of $150 million as consideration to buy rights to the drug candidate and Promedior.

TOPICS:

Illinois First to Lock Painkiller Pill Bottles

August 31, 2015 11:48 am | by The Associated Press | Comments

The numerical locking devices will be similar to those used on gym lockers.

TOPICS:

Hemp Farmer Says Startup Going Slow

August 31, 2015 11:27 am | by Jeff Barnard, Associated Press | Comments

Some are saying that fertile seed is expensive and hard to come by because the federal government prohibits imports. Harvesting machinery is also expensive and facilities for processing the plants into fiber, seed and oil are sparse.

TOPICS:

Labs Seeing Revenue Growth from Marijuana Testing

August 28, 2015 1:05 pm | by PRNewswire | Comments

For example, Las Vegas could become one of the largest medical marijuana markets in the country because Nevada allows dispensaries to sell to patients from other states. The city's 42 million annual visitors could create a 459,000-pound demand.

TOPICS:
Advertisement

Sedative Access Stirs Different Death Penalty Reactions in Tennessee, Mississippi

August 27, 2015 1:28 pm | by Lucas L. Johnson II, Jeff Amy, Associated Press | Comments

Limited access to sodium thiopental has led some states to use a one-drug mix that has been met with varying legal rulings.

TOPICS:

Health Workers Wasting Expensive Malaria Drugs?

August 27, 2015 1:17 pm | by London School of Hygiene & Tropical Medicine | Comments

Many health workers in malaria endemic countries usually treat patients based on their signs and symptoms without testing their blood for the presence of malaria parasites, as recommended by the World Health Organization.

TOPICS:

New Research on Probiotics and GI Colonization

August 27, 2015 1:08 pm | by Society for Healthcare Epidemiology of America | Comments

The research team sought to determine if the probiotic Lactobacillus rhamnosus GG could prevent gastrointestinal colonization of multi-drug resistant organisms.

TOPICS:

Novo Nordisk Increases Diabetes Drug Production in U.S., Denmark

August 27, 2015 12:58 pm | by Emery P. Dalesio, Associated Press | Comments

The Danish drugmaker is opening new factories in North Carolina and Denmark to keep up with demand for diabetes medications.

TOPICS:

FDA Provides Naming Rules for Biosimilars

August 27, 2015 12:44 pm | Comments

Many newer biologics cost more than $100,000 per year and account for nearly 30 percent of all U.S. drug spending. For decades they have not faced generic competition because the FDA lacked a system to approve cheaper versions.

TOPICS:

U.S. Economy Surged in Second Quarter

August 27, 2015 12:30 pm | by Martin Crutsinger, AP | Comments

One analyst is forecasting that the economy will slow its growth to around 2.8 percent in the current quarter, but accelerate in the October-December period as long as the recent market turbulence does not inflict long-lasting damage.

TOPICS:

Cannabis & the Brain: Studies & Associations

August 26, 2015 12:28 pm | by The JAMA Network Journals | Comments

The studies tried to compare the impact of cannabis (marijuana) on brain development in varying sub-sets.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading